Novartis Investigative Site

Bunkyo, Tokyo 113-8519

0 studies enrolling now · 1 studies all time

What they study most

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Studies at this site

• Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. — Completed